Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.64%5.28M | -4.76%4.9M | 16.94%4.6M | 37.49%18.13M | -7.31%4.32M | 20.59%4.73M | 66.68%5.15M | 151.74%3.93M | -5.18%13.18M | 87.73%4.66M |
| Operating revenue | 11.64%5.28M | -4.76%4.9M | 16.94%4.6M | 37.49%18.13M | -7.31%4.32M | 20.59%4.73M | 66.68%5.15M | 151.74%3.93M | -5.18%13.18M | 87.73%4.66M |
| Cost of revenue | 52.90%1.91M | 18.49%1.7M | 72.89%1.37M | 12.39%4.99M | -32.23%1.51M | 35.19%1.25M | 75.19%1.44M | 70.63%794.45K | 11.65%4.44M | 124.14%2.23M |
| Gross profit | -3.17%3.37M | -13.75%3.2M | 2.78%3.22M | 50.24%13.13M | 15.62%2.81M | 16.09%3.48M | 63.60%3.71M | 186.19%3.14M | -11.93%8.74M | 63.33%2.43M |
| Operating expense | 28.10%4.65M | 19.96%3.5M | 31.68%4.4M | 14.86%14.71M | 0.08%4.83M | 30.42%3.63M | 9.95%2.92M | 30.35%3.34M | 24.31%12.81M | 144.54%4.82M |
| Selling and administrative expenses | -23.62%780.7K | 1.92%713.57K | -24.41%709.25K | -5.42%3.55M | -49.52%893.36K | 59.89%1.02M | -20.87%700.1K | 102.20%938.23K | 71.53%3.76M | 81.21%1.77M |
| -General and administrative expense | -23.62%780.7K | 1.92%713.57K | -24.41%709.25K | -5.42%3.55M | -49.52%893.36K | 59.89%1.02M | -20.87%700.1K | 102.20%938.23K | 71.53%3.76M | 81.21%1.77M |
| Other operating expenses | 48.40%3.86M | 25.65%2.79M | 53.59%3.69M | 23.28%11.16M | 28.81%3.93M | 21.62%2.6M | 25.36%2.22M | 14.46%2.4M | 11.56%9.05M | 206.65%3.05M |
| Operating profit | -769.45%-1.28M | -137.78%-299.63K | -481.50%-1.17M | 61.23%-1.58M | 15.67%-2.02M | -167.74%-146.77K | 305.64%793.18K | 86.24%-201.59K | -978.90%-4.07M | -392.59%-2.4M |
| Net non-operating interest income (expenses) | 18.56%-936.63K | 4.10%-685.22K | -36.89%-623.64K | -198.85%-2.79M | -45.13%-474.8K | -699.18%-1.15M | -81.46%-714.49K | -289.07%-455.57K | 5.35%-935.22K | 26.62%-327.16K |
| Non-operating interest income | 1,052.48%155.61K | 924.14%176.52K | 380.60%151.15K | ---- | ---- | -81.01%13.5K | --17.24K | --31.45K | ---- | ---- |
| Non-operating interest expense | -5.24%969.53K | 36.27%729.78K | 94.20%660.17K | 198.85%2.79M | 190.41%863.2K | 533.17%1.02M | 36.02%535.54K | 190.33%339.95K | -5.35%935.22K | -33.33%297.23K |
| Total other finance cost | -12.61%122.71K | -32.73%131.96K | -22.07%114.62K | ---- | ---- | 162.89%140.42K | --196.18K | --147.07K | ---- | ---- |
| Other net income (expenses) | 2,069.53%240.64K | 117.91%53.15K | 150.00%85.47K | 144.06%74.37K | 729.51%11.09K | 114.50%24.39K | -114.80%-170.94K | -263.37%-168.81K | ||
| Special income (charges) | 2,069.53%240.64K | --0 | --53.15K | 150.00%85.47K | --74.37K | --11.09K | --0 | --0 | -114.80%-170.94K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 114.80%170.94K | ---- |
| -Less:Other special charges | -2,069.53%-240.64K | ---- | ---53.15K | ---85.47K | ---74.37K | ---11.09K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | 729.51%11.09K | ---- | 114.50%24.39K | ---- | ---- |
| Income before tax | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,910.60%-1.29M | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,910.60%-1.29M | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M |
| Net income continuous operations | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,910.60%-1.29M | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,910.60%-1.29M | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -53.38%-1.97M | -1,351.56%-984.85K | -165.19%-1.74M | 17.14%-4.29M | 16.28%-2.42M | -1,910.60%-1.29M | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | -709.06%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | -709.06%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.